Teladoc Health, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Teladoc Health, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Growth Efficiency Ratio: Sales grew 5% in 3 years; of every extra $100 of sales, $10,930 became extra profit. Higher than almost all Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 26.7 times by its yearly operating cash. Higher than 91% of Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $10 tied up three years earlier. Less money tied up than 85% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
2.1×Over the last 3 years its own operating cash covered its investment spending (capex) 2.1 times.
Higher than 75% of Healthcare companies in United States.
Cash Locked Ratio
$6For every $100 of sales, $6 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $10 tied up three years earlier.
Less money tied up than 85% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 2/3Sales grew in 1 of the last 3 years; profit grew in 2 of 3.
Steadier than 50% of Healthcare companies in United States.
Growth Efficiency Ratio
$10,930Sales grew 5% in 3 years; of every extra $100 of sales, $10,930 became extra profit.
Higher than almost all Healthcare companies in United States.
Asset Productivity Ratio
+5% / -34%In 3 years sales changed by +5% while total assets changed by -34%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
26.7×Debt due within a year is covered 26.7 times by its yearly operating cash.
Higher than 91% of Healthcare companies in United States.
Cash Cushion Ratio
−23%Debt, after subtracting cash, equals 23% of its market value (net debt).
Lower than 85% of Healthcare companies in United States.
Tangible Assets Ratio
45%Of every $100 the company owns, $45 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 84% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 77% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Teladoc Health, Inc. made a loss over the last year. Teladoc Health, Inc. owes $0.53 for every $1 it owns. Teladoc Health, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTeladoc Health, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.88The share price is 0.88 times Teladoc Health, Inc.'s book value per share, lower than 81% of Healthcare companies in United States.
Market cap
$1.1 BThe total market value of all of Teladoc Health, Inc.'s shares at today's price (share price × number of shares), larger than 66% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$1.3 BWhat Teladoc Health, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$7.21Net worth divided by the number of shares. The share price of $6.32 is 0.9 times this, which is the P/B above.
Return on equity (ROE)
-13.0%Teladoc Health, Inc. lost 13.0% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
Owes vs Owns
0.53×Teladoc Health, Inc. owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Dividend yield
NoneTeladoc Health, Inc. does not currently pay a dividend.
Revenue growth
-2%Revenue fell 2% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Profit growth
LossTeladoc Health, Inc. made a loss in each of the last two years.
Profit margin
-7.9%Teladoc Health, Inc. lost $8 for every $100 of revenue.
Interest cover
Not coveredTeladoc Health, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTeladoc Health, Inc. had $259 M more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Teladoc Health, Inc.: $1.1 B ÷ $1.3 B (30 Jun 2026) = 0.9.
What is Teladoc Health, Inc.'s return on equity?
Teladoc Health, Inc. lost 13.0% of its shareholders' money over the last year, higher than 69% of Healthcare companies in United States.
How much does Teladoc Health, Inc. owe compared with what it owns?
Teladoc Health, Inc. owes $0.53 for every $1 it owns (moderate), higher than 59% of Healthcare companies in United States.
Does Teladoc Health, Inc. pay a dividend?
No. Teladoc Health, Inc. does not currently pay a dividend.
Is Teladoc Health, Inc.'s revenue growing?
Revenue fell 2% in the year to Dec 2025, and grew 2% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.